Two Sigma Advisers’s Carisma Therapeutics CARM Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-22,600
| Closed | -$13.8K | – | 2600 |
|
|
2022
Q4 | $13.8K | Buy |
+22,600
| New | +$13.8K | ﹤0.01% | 2447 |
|
|
2022
Q1 | – | Sell |
-353,185
| Closed | -$288K | – | 2750 |
|
|
2021
Q4 | $288K | Sell |
353,185
-1,916,933
| -84% | -$1.56M | ﹤0.01% | 2153 |
|
|
2021
Q3 | $1.8M | Sell |
2,270,118
-496,200
| -18% | -$394K | ﹤0.01% | 1314 |
|
|
2021
Q2 | $12.8M | Sell |
2,766,318
-212,900
| -7% | -$984K | 0.03% | 476 |
|
|
2021
Q1 | $7.75M | Buy |
2,979,218
+2,260,200
| +314% | +$5.88M | 0.02% | 673 |
|
|
2020
Q4 | $971K | Buy |
719,018
+578,600
| +412% | +$781K | ﹤0.01% | 1579 |
|
|
2020
Q3 | $197K | Buy |
140,418
+94,100
| +203% | +$132K | ﹤0.01% | 2159 |
|
|
2020
Q2 | $33K | Buy |
46,318
+10,500
| +29% | +$7.48K | ﹤0.01% | 2440 |
|
|
2020
Q1 | $20K | Buy |
35,818
+8,778
| +32% | +$4.9K | ﹤0.01% | 2413 |
|
|
2019
Q4 | $28K | Buy |
+27,040
| New | +$28K | ﹤0.01% | 2316 |
|
|
2019
Q2 | – | Sell |
-10,536
| Closed | -$11K | – | 2321 |
|
|
2019
Q1 | $11K | Hold |
10,536
| – | – | ﹤0.01% | 2266 |
|
|
2018
Q4 | $15K | Sell |
10,536
-17,800
| -63% | -$25.3K | ﹤0.01% | 2318 |
|
|
2018
Q3 | $61K | Sell |
28,336
-19,700
| -41% | -$42.4K | ﹤0.01% | 2170 |
|
|
2018
Q2 | $94K | Buy |
+48,036
| New | +$94K | ﹤0.01% | 2279 |
|
|
2015
Q3 | – | Sell |
-34,620
| Closed | -$98K | – | 1821 |
|
|
2015
Q2 | $98K | Buy |
+34,620
| New | +$98K | ﹤0.01% | 1809 |
|